Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Study of BOW015 (Infliximab-EPIRUS) and Infliximab in Patients With Active Rheumatoid Arthritis on Stable Methotrexate: The UNIFORM Study

NCT02683564 is registered in ClinicalTrials.gov with Epirus Biopharmaceuticals (Switzerland) GmbH as lead sponsor.

NCT NCT02683564
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02683564 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Study of BOW015 (Infliximab-EPIRUS) and Infliximab in Patients With Active Rheumatoid Arthritis on Stable Methotrexate: The UNIFORM Study
Lead sponsor
Epirus Biopharmaceuticals (Switzerland) GmbH
Phase
Phase 3
Overall status
Unknown status
Start date
February 29, 2016
Completion date
Not reported
Enrollment
548 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

rheumatoid arthritis